Should Vascular Surgery Patients Be Screened Preoperatively for Methicillin-Resistant Staphylococcus aureus?
Authors:
- Bruce Y. LeeBLBruce Y. Lee
- Becky Y. TsuiBTBecky Y. Tsui
- Rachel R. BaileyRBRachel R. Bailey
- Kenneth J. SmithKSKenneth J. Smith
- Robert R. MuderRMRobert R. Muder
- G. Jonathan LewisGLG. Jonathan Lewis
- Lee H. HarrisonLHLee H. Harrison
- 1 December 2009
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 30 (12) , 1158-1165
Abstract
Background.: Methicillin-resistant Staphylococcus aureus (MRSA) can cause severe infection in patients who are undergoing vascular surgical operations. Testing all vascular surgery patients preoperatively for MRSA and attempting to decolonize those who have positive results may be a strategy to prevent MRSA infection. The economic value of such a strategy has not yet been determined.Methods.: We developed a decision-analytic computer simulation model to determine the economic value of using such a strategy before all vascular surgical procedures from the societal and third-party payer perspectives at different MRSA prevalence and decolonization success rates.Results.: The model showed preoperative MRSA testing to be cost-effective (incremental cost-effectiveness ratio, <$50,000 per quality-adjusted life year) when the MRSA prevalence is ≥0.01 and the decolonization success rate is ≥0.25. In fact, this strategy was dominant (ie, less costly and more effective) at the following thresholds: MRSA prevalence ≥0.01 and decolonization success rate ≥0.5, and MRSA prevalence ≥0.025 and decolonization success rate ≥0.25.Conclusion.: Testing and decolonizing patients for MRSA before vascular surgery may be a cost-effective strategy over a wide range of MRSA prevalence and decolonization success rates.Keywords
This publication has 30 references indexed in Scilit:
- International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?Health Economics, 2009
- Surveillance Cultures for Detection of Methicillin-Resistant Staphylococcus aureus: Diagnostic Yield of Anatomic Sites and Comparison of Provider- and Patient-Collected SamplesInfection Control & Hospital Epidemiology, 2009
- Is Throat Screening Necessary To Detect Methicillin-Resistant Staphylococcus aureus Colonization in Patients upon Admission to an Intensive Care Unit?Journal of Clinical Microbiology, 2007
- Economics of Central Line-Associated Bloodstream InfectionsAmerican Journal of Medical Quality, 2006
- An Audit Demonstrating a Reduction in MRSA Infection in a Specialised Vascular Unit Resulting from a Change in Infection Control ProtocolEuropean Journal of Vascular and Endovascular Surgery, 2006
- Bias in published cost effectiveness studies: systematic reviewBMJ, 2006
- Methicillin Resistant Staphylococcus aureus in Patients Undergoing Major AmputationEuropean Journal of Vascular and Endovascular Surgery, 2001
- The Impact of MRSA on Vascular SurgeryEuropean Journal of Vascular and Endovascular Surgery, 2001
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- The utility of different health states as perceived by the general publicJournal of Chronic Diseases, 1978